Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
Tokumaru S, Koizumi T, Sekino Y, Takeuchi N, Nakata S, Miyagawa Y, Kitazawa M, Muranaka F, Nakamura S, Koyama M, Yamamoto Y, Ehara T, Hondo N, Soejima Y.
Tokumaru S, et al. Among authors: nakata s.
Oncology. 2021;99(10):632-640. doi: 10.1159/000517344. Epub 2021 Jul 19.
Oncology. 2021.
PMID: 34280933